Woodline Partners LP - Significant Ownership

Signature - Title
/s/ Erin Mullen - Erin Mullen, General Counsel & Chief Compliance Officer
Location
San Francisco, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Woodline Partners LP.

Notify me when Woodline Partners LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Woodline Partners LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SABS SAB Biotherapeutics, Inc. Common Stock, par value $0.0001 per share 9.9% $14.3M 7.13M Woodline Partners LP Sep 30, 2025
ALGS Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share 8.7% $4.61M -$493K 468K -9.67% Woodline Partners LP Sep 30, 2025
AIRO AIRO Group Holdings, Inc. Common Stock, par value $0.000001 per share 8.5% $52.9M $15.4M 2.75M +41% Woodline Partners LP Sep 30, 2025
OM Outset Medical, Inc. Common Stock, par value $0.001 per share 7.5% $13.5M 1.33M Woodline Partners LP Mar 31, 2025
PLRX PLIANT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 7.3% $6.67M 4.5M Woodline Partners LP Sep 30, 2025
ZVRA ZEVRA THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 6.2% $33.1M 3.48M Woodline Partners LP Sep 30, 2025
EQ Equillium, Inc. Common Stock, par value $0.0001 per share 5.9% $5.02M 3.51M Woodline Partners LP Sep 30, 2025
TNGX Tango Therapeutics, Inc. Common Stock, par value $0.001 per share 5.6% $41.6M 6.03M Woodline Partners LP Jun 30, 2025
VSH VISHAY INTERTECHNOLOGY INC Common Stock, par value $0.10 per share 5.5% $104M 6.81M Woodline Partners LP Sep 30, 2025
TNYA Tenaya Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.99% $10.2M $3.48M 9M +52.1% Woodline Partners LP Jun 30, 2025
SGMT Sagimet Biosciences Inc. Series A Common Stock, par value $0.0001 per share 4.8% $10.3M -$7.21M 1.5M -41.2% Woodline Partners LP Sep 30, 2025
GRDN Guardian Pharmacy Services, Inc. Class A Common Stock, par value $0.001 per share 4.5% $9.49M 415K Woodline Partners LP Dec 31, 2024
TARA Protara Therapeutics, Inc. Common Stock, par value $0.001 per share 3.9% $5.19M 1.33M Woodline Partners LP Dec 31, 2024
TVTX Travere Therapeutics, Inc. Common Stock, par value $0.0001 per share 2.4% $28.5M 2.11M Woodline Partners LP Dec 31, 2024

Schedules 13D/G Reported by Woodline Partners LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.